________________________________________________________________________

April 30, 2021

To,

National Stock Exchange of India Limited,

BSE Limited,

Exchange Plaza, 5th Floor,

Market Operations Dept.

Plot No. C/1, G Block,

P. J. Towers,

Bandra Kurla Complex,

Dalal Street,

Bandra (East),

Mumbai-400001.

Mumbai-400051.

Scrip Code: 532321

Scrip Name: Cadilahc

Dear Sir/ Madam,

Sub: Disclosure under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

In furtherance to our intimation to the stock exchanges on March 31, 2021, that the partnership interest of Cadila Healthcare Limited in ABCD Technologies LLP (to be renamed as IndoHealth Services LLP) stood revised from 20% to 12.5% entitling 12.5% share of profit/loss and voting rights, we hereby intimate that post admission of 9 new partners on April 30, 2021, in ABCD Technologies LLP, the partnership interest in ABCD Technologies LLP now stands revised at 6.45% entitling 6.45% share of profit/loss and voting rights.

This is for your information and dissemination.

Thanking you,

Yours faithfully,

For, CADILA HEALTHCARE LIMITED

DHAVAL NARENDRA SONI

Digitally signed by

DHAVAL NARENDRA SONI Date: 2021.04.30 20:16:57 +05'30'

DHAVAL N. SONI

COMPANY SECRETARY

Regd. Office: "Zydus Corporate Park" Scheme No. 63, Survey No. 536, Khoraj (Gandhinagar), Nr. Vaishnodevi Circle,

S.G. Highway, Ahmedabad-382481.

Phone: +91-07971800000,+91-79-48040000;Website: www.zyduscadila.com; CIN: L24230GJ1995PLC025878

Attachments

  • Original document
  • Permalink

Disclaimer

Cadila Healthcare Limited published this content on 01 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 May 2021 07:02:02 UTC.